Introduction {#s1}
============

Chronic kidney disease (CKD) has become a worldwide health problem with an increasing prevalence. In Europe, the adjusted prevalence of CKD stages 1--5 varied from 3.3% to 17.3%, 6.7% in South China, and 18.3% in Southwest China ([@B7]). Previous authors have reported that risk factors may accelerate the progression of CKD. These factors include older age, male, diabetes, proteinuria, hypertension ([@B43]; [@B55]) and systemic inflammatory levels, among which systemic inflammation induced by intestinal toxins ([@B3]), is considered as one of the most important risk factors, and has become a research hot spot in recent years. The intestinal toxins, including trimethylamine-N-oxide (TMAO), indoxyl-sulfate (IS), P-cresol (PCS) and lipopolysaccharide (LPS) ([@B52]; [@B23]; [@B35]), are reportedly elevated due to a leaky intestinal barrier following CKD. These intestinal toxins can cause oxidative stress and inflammation.

The human intestinal barrier is composed of mucous, mechanical, and immune barriers. The mechanical barrier is the basic barrier, composed mainly of intestinal epithelial cells and tight connections between cells ([@B16]). The inflammatory state in the colonic wall of animals with CKD has been shown to impair the intestinal epithelial barrier structure and function, which contributes to the translocation of endotoxins, microbial fragments, and other noxious luminal products into circulation ([@B58]; [@B33]; [@B59]).

Recent studies have shown that intestinal barrier damage is associated with gut microbiota disorders. The proportion of bacteria in the human gastrointestinal tract is maintained within a certain range ([@B19]), these bacteria form a symbiotic relationship with the human body and participate in human metabolism, immunity, and other physiological activities ([@B57]). In patients with CKD, the homeostatic balance among gut microbiota is disrupted, with a decrease in the proportion of probiotic bacteria and an increase in that of pathogenic bacteria. Probiotic bacteria include mainly *Lactobacillus* and *Bifidobacteria*, which contain protein machinery for butyrate production, a derivative of short chain fatty acids. Pathogenic bacteria include mainly *Clostridium* *difficile*, *Escherichia coli*, and *Clostridium perfringens*. These bacteria have protein machinery to produce ammonia and intestinal toxins, which can corrode the intestinal barrier ([@B68]). Therefore, changes in the gut microbiota are closely related to changes in intestinal barrier function, and the intestinal tract is an important target for CKD treatment. However, clinical treatments targeting the intestine, such as intestinal adsorbent and probiotic supplements, are limited and less effective ([@B39]; [@B56]; [@B27]).

Rhubarb comprises the dried roots and rhizomes of *Rheum palmatum* L, *Rheum tanguticum* Maxim. ex Balf, or *Rheum officinale* Baill., belonging to Rheum genus and Polygonaceae family. Rhubarb, used in traditional Chinese herbal medicine, is a strong irritant of the gastrointestinal tract upon oral administration since it contains anthraquinones. Enemas, which are administered *via* the anus, can prevent stimulation of the gastrointestinal tract by oral administration, thereby effectively controlling side effects such as nausea, vomiting, and abdominal distension . Hence, rhubarb is widely used as an enema for its laxative properties across China, especially in CKD. Traditionally, 30 g rhubarb was immersed in 300 mL distilled water for 30 min, then decocted twice with water (300 mL and 100 mL) for 40 min. The resultant extractions were mixed and filtered. The filtrates were concentrated to 100 ml, resulting in a 0.3 g/ml crude drug content for the rhubarb enema. Rhubarb granules present another method of use, which is obtained by decocting, filtering, centrifugation, concentration, and drying processes. One gram rhubarb granule is equivalent to 3 g rhubarb. As a traditional Chinese herbal medicine, rhubarb is widely used in sepsis, severe pancreatitis, and other diseases to protect the intestinal barrier ([@B65]; [@B69]). Besides, rhubarb can slow CKD progression by inhibiting tubulointerstitial fibrosis ([@B75]; [@B76]), which may be related to disrupted intestinal flora regulation in CKD ([@B24]).Our previous study also showed that rhubarb enema could reduce serum uremic toxin and downregulate systemic inflammation and oxidative stress, thereby improving renal interstitial fibrosis ([@B36]; [@B74]). As rhubarb enema acts directly on the intestine, this study was performed to determine whether rhubarb enema could restore intestinal barrier by modifying functional enteric bacteria in 5/6 nephrectomy rats, and further to explain the renal protective mechanism of the therapy.

Materials and Methods {#s2}
=====================

Experimental Animals and Medicinal Intervention {#s2_1}
-----------------------------------------------

This study was performed with 30 male specific pathogen-free (SPF)-grade Sprague--Dawley rats, aged 12 weeks and weighing approximately 180 ± 20 g. The rats were housed in the SPF animal breeding room of the Academy of Chinese Medicine of Guangdong Province and given free access to water. The rats were fed on a 12-h light/dark cycle. This experimental study was approved by the ethics review committee of Guangdong Hospital of Traditional Chinese Medicine (NO., 2018028).

The classic 5/6 nephrectomy (Nx) model was used in this study. Thirty rats were divided randomly into the sham group (n = 10) and CKD group (n = 20) after 5/6 Nx was performed to remove the upper and lower two-thirds of the left kidney. Total right Nx was performed 7 days post-surgery. Rats in the sham group were stripped of the fat sac without Nx. Eight weeks after the operation, rats in the CKD group were divided randomly into the 5/6 Nx model group and the 5/6 Nx + rhubarb enema group.

Rhubarb granules (batch number, 19051281) were obtained from Jiangyin Tianjiang Pharmaceutical Industry Co., Ltd. The herbal materials were authenticated according to Chinese Pharmacopeia, 2015, morphologically and chemically. The voucher species were stored at the Center for Chinese Medicine at Guangdong Hospital of Traditional Chinese Medicine. The rhubarb enema water was prepared with 20 g rhubarb granules dissolved in 100ml distilled water. Rhubarb enema was performed with a dose of 2.12 g/kg once per day for 4 weeks, according to clinical administration ([@B37]). High-performance liquid chromatography--mass spectrometry (HPLC-MS) analysis was conducted to confirm the quality of the rhubarb granules extract ([**Supplementary Table 1**](#SM1){ref-type="supplementary-material"} and [**Figure 1**](#f1){ref-type="fig"}).

![Renal histopathological changes (hematoxylin and eosin (HE) stain). A marked enlargement of the renal tubular lumen, renal tubular atrophy, mononuclear lymphocyte infiltration, and interstitial fibrosis in 5/6Nx compared with Sham group; while these histopathological changes were improved by *rheum palmatum* L enema treatment. Magnifications × 100.](fphar-11-01092-g001){#f1}

Detailed Operation Instructions for Enema {#s2_2}
-----------------------------------------

The rats were fasted for12 h before enema. The rat was held on the rat frame so that the head and neck were behind, the tail and the anus were presented in front, and the tail of the rat faced upward to expose the anus. The abdomen of the rat was stroked to encourage defecation, ensuring that the intestines were empty. The enema solution was maintained at the same temperature of the rat anus (37.5-39 °C). A straight-head gavage needle was inserted about 8 cm into the rat rectum, since research shows that the rat rectum measures approximately 8 cm, the anus was squeezed, and the needle position was fixed. Then, the drug was slowly injected while the anus was pinched for 30 s to 2 min, to retain the enema solution. The enema was administered once a day, for 4 weeks. The drugs and instruments were treated aseptically during this process.

UPLC-ESI-MS Analysis {#s2_3}
--------------------

Chromatographic separation was performed on a Dionex UltiMate, 3000 UPLC system (Thermo Scientific, San Jose, CA, USA). UPLC conditions were as follows: Waters acquity SB-C18 column (4.6 × 100 mm, 1.8 μm, Agilent Technologies, CA, USA); column temperature: 30°C; mobile phase: 0.1% formic acid water (A) and acetonitrile (B); gradient conditions for positive mode analysis: 0--4 min 10--13% B; 4--6 min 13--50% B; 6--10 min 50% B; 10--14 min 50--85% B; 14--18 min 85% B; 18--20 min 85--100%; 20--25 min 100%; re-equilibrate: 10 min; gradient conditions for negative mode analysis: 0--2 min 15% B; 2--4 min 15--55% B; 4--8 min 55% B; 8--14 min 55--70% B; 14--22 min 70--80% B; 22--24 min 80--100%; 24--28 min 100%; re-equilibrate: 10 min; flowrate: 0.2 ml/min; injection volume: 2 μl. We tested 6 samples from the same batch and measured the peak area every 2 h to investigate the repeatability and stability of the experiment.

MS detection was performed on an Orbitrap mass spectrometer (Thermo Fisher), which was operated in both positive (ESI+) and negative electrospray ionization interface (ESI−). The MS parameters were as follows: heater temperature, 350°C; sheath gas flowrate, 35 arb; aux gas flowrate, 10 arb; sweep gas flowrate, 0 arb; I spray voltage, 3.2 kV; capillary temperature: 300°C; mass range: m/z 150--1,500. Repeatability and stability were tested as above.

Biochemical Detection {#s2_4}
---------------------

Serum samples were sent to the Laboratory Department of University City Hospital of Guangdong Hospital of Traditional Chinese Medicine, serum creatinine, blood urea nitrogen, and serum albumin were detected using a Roche biochemical analyzer (Hitachi, 7180, Tokyo, Japan).

Histopathological Studies {#s2_5}
-------------------------

Kidney and colon tissues were dehydrated and embedded, and paraffin specimens were made and sectioned for hematoxylin and eosin (HE) staining. Histological images were captured using a microscope (Hitachi).

Enzyme-Linked Immunosorbent Assay {#s2_6}
---------------------------------

The levels of interleukin (IL)-1β, IL-6, and lipopolysaccharide (LPS) in serum and kidney tissues were detected using ELISAs. IL-1β (ab100768, Abcam) and IL-6 (ab100772, Abcam) assay kits were obtained from Abcam (Cambridge, UK). LPS assay kit (OKEH02594) were obtained from AVIVA SYSTEMS BIOLOGY (California, USA).

Western Blot Analysis {#s2_7}
---------------------

Colon tissues were lysed in 1 mL RIPA lysis buﬀer containing 1 mM PMSF and 1% phosphatase inhibitor cocktail (Applygen Technologies Inc., Beijing, China). Protein concentrations were measured using a Pierce BCA protein assay kit (Thermo Fisher Scientific, Waltham, Massachusetts, USA). Samples (25--50 μg) were separated using 10% SDS--PAGE and then wet transferred to polyvinylidene diﬂuoride membranes (PVDF, EMD Millipore, Burlington, USA). Membranes were blocked with 5% non-fat milk and incubated with primary antibodies against occludin (1:1000; ab167161, Abcam), claudin-1 (1:1000; ab180158, Abcam), ZO1 (1:1000; CST\#13663,Cell Signaling Technologies, Darmstadt, Germany), TLR4 (1:500; sc-293072, Santa Cruz), NF-κB (1:1000; CST\#8242, Cell Signaling Technologies), phosphorylated (p) NF-κB (1:1000; CST\#8214, Cell Signaling Technologies), MyD88 (1:1000; ab2064, Abcam), or β-actin (1:1000; CST\#4970, Cell Signaling Technologies) and incubated overnight at 4°C with gentle shaking. The membranes were washed three times and then incubated with a horseradish peroxidase--linked secondary antibody (1:1000; Beyotime, Jiangsu, China). Immunoreactivity was detected using an enhanced chemiluminescence reagent (WBKLS0500; EMD Millipore) and quantiﬁed using Image Lab 5.2.1 software (Bio-Rad, Hercules, CA, USA).

Stool Specimen Collection {#s2_8}
-------------------------

A disposable sterile medical pad was placed on the operating table and the rat was held on the rat frame so that the head and neck were behind, the tail and anus were presented in front, and the tail of the rat faced upward to expose the anus. The abdomen was stroked to promote defecation. Using sterile forceps, fresh feces was collected, placed into EP tubes, and quickly placed in liquid nitrogen. Thereafter, samples were stored at -80°C.

Genomic DNA Extraction and 16S Amplification {#s2_9}
--------------------------------------------

DNA samples were quantified using a NucleoSpin Soil Kit - Macherey-Nagel (Biocompare, Germany) and then transferred to BGI Genomics for gene sequencing of the V4 region of the 16S rRNA gene with the Hiseq, 2500 (Illumina, California, USA). PCR primers used for the 16S rRNA amplicon libraries were 515F and 806R.

Bioinformatics and Biostatistics {#s2_10}
--------------------------------

The raw sequencing data were filtered to obtain clean reads by eliminating adapter contamination and low quality. Overlapping paired-end reads were merged to tags using FLASH (version 1.2.11), then clustered to operational taxonomic units (OTUs) at 97% sequence similarity by USEARCH (version 7.0.1090). Taxonomic ranks were assigned to OTU representative sequences using the Ribosomal Database Project Classifier (version 2.2) trained on the database Greengene_2013_5\_99, using confidence values of 0.6 as cutoff values. Functional classification schemes of KEGG Orthology were predicted using PICRUSt (version 1.1.3).

All statistical analyses were performed using R software (version 3.5.0; R Foundation for Statistical Computing, Vienna, Austria). Alpha diversity (Shannon index) and principal coordinate analysis (PCoA) based on Bray-Curtis dissimilarity matrices were calculated at the genus level for 16S rDNA gene sequencing using the vegan package. The Kruskal-Wallis test was performed to compare alpha diversity among groups. Permutational multivariate analysis of variance (PERMANOVA) was performed on dissimilarity matrices to assess the effects of groups with 10,000 permutations in R (version 3.5.0, vegan package). Linear discriminant analysis of effect size (LEfSe) was used to identify features that differed significantly among groups, as well as their effect sizes. EnvFit analysis was used to determine the effect size and significance of each covariate among the centroids of each group with 999 permutations using the envfit function; redundancy analysis (RDA) was performed using the rda command of the vegan package. Spearman Rank Correlation was performed to determine correlations between differential microbiota/KO and environmental variables; the false discovery rate was used to assess the significance of differences with *P* \< 0.05.

Statistical Method {#s2_11}
------------------

SPSS software (version 19.0, IBM Corp, Armonk, NY, USA) was used for statistical analysis, and the measurement data were assessed for adherence to normal distribution. Independent-samples T tests were used to compare normally distributed data with homogeneous variance between two groups. Single-factor analysis of variance was used for multi-group data. The non-parametric Mann-Whitney U test was used to compare non-normally distributed data with heterogeneous variance between two groups. The nonparametric rank-sum test was used for comparison of rank data between groups. *P* values \< 0.05 were considered statistically significant.

Results {#s3}
=======

Standardization of Rhubarb Granules {#s3_1}
-----------------------------------

Before drug treatment, rhubarb granules were chemically standardized. An HPLC-MS approach was established to reveal the chemical profile of rhubarb granules and quantify the main ingredients in the extract. Using the respective individual standards, five compounds, including gallic acid, aloe-emodin-β-D-glucopyranoside, emodin-β-[d]{.smallcaps}-glucopyranoside, rhein, and emodin, were identified from rhubarb granules ([**Supplementary Table 1**](#SM1){ref-type="supplementary-material"} and [**Figure 1**](#f1){ref-type="fig"}). The chemical analysis of rhubarb granules here served as quality control for the reproducibility of the below animal study.

Rhubarb Enema Reduces Blood Creatinine and Improves Renal Fibrosis {#s3_2}
------------------------------------------------------------------

At the end of the experiment, the serum creatinine and blood urea nitrogen levels of rats in the 5/6 Nx model and 5/6 Nx + rhubarb enema groups were significantly higher than those of the sham group(*P*\<0.001), while the serum creatinine level was significantly lower in the 5/6 Nx + rhubarb enema group than in the 5/6 Nx model group (*P*=0.042) ([**Table 1**](#T1){ref-type="table"}).

###### 

Physical and Biochemical characteristics.

  Parameters              Sham (n=10)    5/6Nx (n=10)   5/6Nx + rhubarb (n=10)
  ----------------------- -------------- -------------- ------------------------
  Body weight, g          516.8 ± 35.6   528.3 ± 52.2   523.6 ± 45.3
  Cr, umol/L (before)     30.9 ± 2.3     58.1 ± 6.1\*   /
  Urea, mmol/L (before)   7.24 ± 0.7     13.2 ± 1.4\*   /
  Cr, umol/L (after)      45.0 ± 7.4     76.3 ± 8.5\*   67.1 ± 5.1\#
  Urea, mmol/L(after)     6.8 ± 1.1      11.0 ± 1.1\*   9.9 ± 1.5
  Alb, g/L                41.5 ± 2.8     40.3 ± 2.8     40.7 ± 1.4
  Urine volume, mL        22.3 ± 10.1    25.0 ± 8.7     26.3 ± 7.3
  24h Urine protein, g    0.9 ± 0.6      0.9 ± 0.5      0.9 ± 0.3
  ALT/AST                 3.9 ± 1.2      4.1 ± 1.2      4.0 ± 0.6

Alb, albumin; Cr, creatinine; ALT, alanine transaminase; AST, aspartate transaminase. \*Sham Vs 5/6Nx; \#5/6Nx Vs 5/6Nx + rhubarb. Before, before rhubarb enema treatment; after, after rhubarb enema treatment.

In the 5/6 Nx model group, HE staining of renal tissues showed obvious enlargement of the renal tubular lumen, as well as renal tubular atrophy, mononuclear lymphocyte infiltration, and interstitial fibrosis; these histopathological changes were improved by rhubarb enema treatment ([**Figure 1**](#f1){ref-type="fig"}). These results demonstrated that rhubarb enema could improve renal functionality to a certain degree.

Rhubarb Enema Improved Systemic Inflammation {#s3_3}
--------------------------------------------

IL-1β and IL-6 levels in serum and kidney tissues of the 5/6 Nx model and 5/6 Nx + rhubarb enema groups were significantly higher than those of the sham group (*P*\<0.01), whereas those of the 5/6 Nx + rhubarb enema group were in between, lower than those of the model group with statistical significant, but higher than those of the sham group. Serum LPS levels in the 5/6 Nx model group and the 5/6 Nx + rhubarb enema group were significantly higher than that of the sham group (*P*\<0.01), while that of the 5/6 Nx + rhubarb enema group were in between, significantly lower than that of the 5/6 Nx model group (*P*\<0.01), but higher than that of the sham group ([**Table 2**](#T2){ref-type="table"}). These results suggest that rhubarb enema intervention can potentially reduce systemic inflammation.

###### 

systemic inflammation levels.

  Parameters      IL-1β            IL-6             LPS                                  
  --------------- ---------------- ---------------- ------------------- ---------------- -----------------
  Sham            4.7 ± 2.9        7.4 ± 2.0        35.6 ± 33.7         5.4 ± 2.7        25.9 ± 15.5
  Model           29.1 ± 9.9\*     14.4 ± 0.9\*     459.3 ± 137.2\*     16.7 ± 1.8\*     109.5 ± 33.3\*
  rhubarb enema   14.2 ± 3.4^\#^   11.9 ± 1.7^\#^   218.1 ± 105.7^\#^   13.8 ± 2.1^\#^   55.6 ± 10.7^\#^

LPS, lipopolysaccharide. \*Sham Vs 5/6Nx; \#5/6Nx Vs 5/6Nx + rhubarb enema.

Rhubarb Enema Improved Intestinal Barrier Integrity {#s3_4}
---------------------------------------------------

In the 5/6Nx model group, HE staining of colon tissue showed obvious edema in the lamina propria and mucosal layer of the colon compared with the sham group. Moreover, obvious infiltration of lymphocytes and monocytes in the mucosal layer was observed in the 5/6 Nx model group. Following rhubarb enema, the edema in the lamina propria and mucosal layer was significantly improved, and the infiltration of inflammatory cells in the mucosal layer was reduced ([**Figure 2A**](#f2){ref-type="fig"}).

![Rhubarb enema improved the intestinal barrier. **(A)** Colon histopathological changes (hematoxylin and eosin (HE) stain). Compared with the sham group, the lamina propria and mucosal layer of the colon were obvious oedematous; moreover, obvious infiltration of lymphocyte monocytes in the mucosal layer was observed in the 5/6Nx model group. Following rhubarb enema, the edema in the lamina propria and mucosal layer was significantly improved, and the infiltration of inflammatory cells in the mucosal layer was reduced. Magnifications × 100. **(B)** The intestinal mucosal barrier (ZO1, occludin, and claudin-1) in colon tissues was significantly lower in the 5/6Nx model rat; this expression was significantly higher in the 5/6Nx + rhubarb enema group than in the 5/6Nx model group. **(C)**TLR4 signaling pathways is activated in in the colon tissue of 5/6Nx model rat while significantly reduced by rhubarb enema treatment.](fphar-11-01092-g002){#f2}

The expression of key indicators of the intestinal mucosal barrier (occludin, claudin-1, and ZO1) in colon tissues was significantly lower in the 5/6 Nx model and 5/6 Nx + rhubarb enema groups than the sham group (*P*\<0.01; *P* =0.042*; P*\<0.01); this expression was significantly higher in the 5/6 Nx + rhubarb enema group than in the 5/6 Nx model group (*P*\<0.01; *P*\<0.01; *P* =0.025, [**Figure 2B**](#f2){ref-type="fig"}).

TLR4 signaling pathways have been shown to be activated in the colon tissue of CKD model rats. In this study, the expression levels of TLR4, NF-κB, pNF-κB, and MyD88 in the colon tissue were significantly higher in the 5/6Nx model and 5/6Nx + rhubarb enema groups than in the sham group (*P* \< 0.01, respectively). Rhubarb enema treatment significantly reduced expression levels of TLR4, NF-κB, pNF-κB, and MyD88 in the colon tissue relative to those of the 5/6Nx model group, (*P* = 0.039; *P* = 0.033; P =0.056; *P* = 0.016, [**Figure 2C**](#f2){ref-type="fig"}).These results indicate that rhubarb enema improved the intestinal barrier upon 5/6 Nx.

Changes to Gut Microbiota After Rhubarb Enema Treatment {#s3_5}
-------------------------------------------------------

### Diversity Analysis {#s3_5_1}

Alpha diversity represents the taxonomy richness and unevenness of a micro-ecology. Here we evaluated alpha diversity within each sample and each group by calculating the Shannon index at the genus level. The Shannon index differed significantly among the three groups (*P* = 0.015, Kruskal-Wallis test, [**Figure 3A**](#f3){ref-type="fig"}). It was significantly higher in the 5/6 Nx model group than in the sham group (*P* = 0.0079). Interestingly, the diversity of the rhubarb enema group was lower than that of the 5/6 Nx model group, but higher than that of the sham group. It seems that rhubarb enema tended to correct the disease tendency.

![Rhubarb enema treatment modify the diversity of gut microbiota. The diversity of gut microbiota was significantly different among three groups. **(A)** The Shannon index of the model group was higher than the rhubarb enema group, and significantly higher than the sham group. **(B)** The principal component analysis (PCoA) plots were based on Bray-Curtis distance of the genus levels for 16S rDNA gene sequencing. Individuals (represented by points) were clustered into 3 groups. Permutational multivariate analysis of variance (PERMANOVA) was performed on dissimilarity matrices to assess the effects of groups with 10,000 permutations.](fphar-11-01092-g003){#f3}

We evaluated the beta diversity of the samples using PCoA based on Bray-Curtis distance to investigate the difference of microbiota composition among groups. Individuals were clustered into three clusters ([**Figure 3B**](#f3){ref-type="fig"}). Interestingly, the individuals in the same group form a cluster, the inter-group distance was significantly greater than the intra-group distance (*P* \< 0.001, 9999 permutations).

### Differential Abundance Analysis {#s3_5_2}

LEfSe analysis was applied to identify differentially abundant bacterial taxa among the three groups, only those taxa that obtain a log LDA score \>2 are ultimately considered. Genera with higher abundance in the sham group included *Lactobacillus*, *Prevotella*, and *Parabacteroides*. Whereas *Methanosphaera*, *Akkermansia*, *Christensenella*, *Adlercreutzia*, *Corynebacterium*, *Coprobacillus*, *RF39* from class *Mollicutes*, *02d06* from family *Clostridiaceae*, one member of family *Erysipelotrichaceae* and two members of order *Clostridiales* (*Lachnospiraceae* and other) were more abundant in the 5/6 Nx group. *Clostridium*, *Alistipes*, *Sutterella*, *S24−7* from order *Bacteroidales*, one member from family *Clostridiaceae*, and one member from family *Enterobacteriaceae* were more abundant in the 5/6 Nx + rhubarb enema group ([**Figure 4**](#f4){ref-type="fig"}).

![Rhubarb enema treatment modify gut microbiota that enriched in different group. LEfSe was further used to analyze differences gut microbial enriched in the three groups.](fphar-11-01092-g004){#f4}

### Impact of Environmental Factors on Microbiota Composition {#s3_5_3}

Envfit function was applied to identify the impact of environmental variables on microbiota variation ([**Figure 5A**](#f5){ref-type="fig"} and [**Supplementary Table 4**](#SM1){ref-type="supplementary-material"}, P \< 0.1, 999 permutations). ZO1, occludin, LPS, and NF-κB exerted the greatest impact on the microbial composition (R2 \> 0.6, P \< 0.01). RDA biplot was used to present the correlation and the impact of environmental variables on the microbiota variation. It revealed that the expression levels of intestinal barrier tight junction proteins (ZO1, occludin, and claudin-1) were positively correlated with each other, and negatively correlated with systematic inflammatory cytokines (IL-6, IL-1β), key proteins of the TLR4 pathway (TLR4, NF-κB, pNF-κB, and MyD88), and LPS. Systematic inflammatory cytokines were positively correlated with key proteins of the TLR4 pathway and LPS. Moreover, ZO1, occludin, and claudin-1 were found to contribute to the microbial variation of the sham group. Systematic inflammatory cytokines, key proteins of the TLR4 pathway and LPS contributed to the microbial variation of the 5/6 Nx group. The 5/6 Nx + rhubarb enema group was located between the 5/6 Nx group and the sham group. It indicated that the contribution of systematic inflammatory cytokines, key proteins of the TLR4 pathway, and LPS gradually decreases, while that of the intestinal barrier tight junction proteins gradually increases microbial variation, upon rhubarb enema treatment ([**Figure 5B**](#f5){ref-type="fig"}).

![The relationships among the gut microbiota, intestinal barrier, and systemic inflammation. Envfit function was applied to identify the impact of environmental variables on the microbiota variation **(A)**. RDA showed that gut microbiota was correlated with systemic inflammation and intestinal barrier indicators in the three groups **(B)**. Spearman rank correlation between differential gut microbiota and intestinal barrier, systemic inflammation **(C)**.](fphar-11-01092-g005){#f5}

Furthermore, spearman's rank correlation was performed to determine correlations between differential microbiota and environmental variables. Genus *Lactobacillus*, *Prevotella*, and *Parabacteroides*, which were enriched in the sham group, were positively correlated with expression levels of intestinal barrier tight junction proteins, and negatively correlated with systematic inflammatory cytokines, key proteins of the TLR4 pathway, and LPS. The results of order *Clostridiales*, genus *Methanosphaera*, *Akkermansia*, *Christensenella*, *02d06* from family *Clostridiaceae*, and *RF39* from class *Mollicutes*, which were enriched in 5/6 Nx group, were reversed. The microbiota enriched in 5/6 Nx + rhubarb enema group were almost independent of environmental variables.

### Differential Function Analysis {#s3_5_4}

Spearman's rank correlation was also performed to determine correlations between differential KOs and environmental variables ([**Figure 5C**](#f5){ref-type="fig"}). Similar to the result of differential microbiota, functional KOs enriched in the 5/6 Nx group were negatively correlated with the expression levels of intestinal barrier tight junction proteins, and positively correlated with systematic inflammatory cytokines, key proteins of the TLR4 pathway, and LPS, especially arginine and proline metabolism. Whereas the result of KOs enriched in the sham group were reversed, such as tyrosine metabolism ([**Figure 6**](#f6){ref-type="fig"}).

![Differential microbiota functional KOs enriched in different groups and the correlated relationship among the gut microbiota functional Kos, intestinal barrier, and systemic inflammation.](fphar-11-01092-g006){#f6}

Discussion {#s4}
==========

Clinical and experimental studies have shown that intestinal barrier defects have been associated with a wide array of diseases, including both enteral disorders such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD) ([@B4]; [@B45]; [@B51]), and extra-intestinal disorders such as nonalcoholic fatty liver disease, pancreatitis, and obesity ([@B38]; [@B70]; [@B69]). The latest study found that intestinal barrier function decreased in CKD as well ([@B2]; [@B5]; [@B44]). Since the glomerular filtration rate is dramatically reduced in CKD ([@B68]), the heavy influx of urea from body fluids to the gastrointestinal tract, was firstly hydrolyzed to ammonia and then converted to ammonium hydroxide (NH4OH), leading to increased intestinal pH. The alternated intestinal milieu together with the accumulation of uremic toxins would damage intestinal tight junction, resulting in the activation of submucosal inflammation and macrophage TLR4--MyD88--NF-κB signaling pathways (Williams et al., 2013; [@B49]; [@B22]). A large number of inflammatory mediators are then produced ([@B48]), increasing damage to intestinal epithelial cells ([@B1]), causing enterogenous harmful metabolites and endotoxins to enter systemic circulation, stimulating the onset of systemic inflammation ([@B50]; [@B59]; [@B6]). Systemic inflammation is an important risk factor for renal fibrosis ([@B33]).

Intestinal barrier is affected by many factors, such as environmental factors, including smoking, diet, use of antibiotics, and hyperoxia ([@B15]; [@B42]) and especially gut microbiota ([@B63]). CKD is often accompanied by gut microbiome alternation in diversity, quantity, structure, function, and performance ([@B28]). According to a previous gut microbiota study of CKD stage 4 and 5 patients, renal failure accompanied an increase in gut microbiota diversity ([@B21]), probably resulting from the overgrowth of pathogenic bacteria. With the decrease of probiotic bacteria in CKD, protective factors, such as SCFAs produced by enterobacteria *Lactobacillus* and *Prevotellaceae* were also decreased. SCFAs play an important role in maintaining the intestinal barrier ([@B30]; [@B20]). While pathogenic bacteria significantly increased in CKD, such as *Alteromonadaceae*, *Cellulomonadaceae*, *Clostridiaceae*, *E. coli*, and *Enterobacteriaceae*, pathogenic factors such as circulating endotoxins and ammonia produced by these bacteria increased, followed by increased damage to the intestinal barrier ([@B60]; [@B68]).

Effective improvement of the intestinal environment is the key to alleviate CKD progression, but current therapies are limited, such as intestinal adsorbent, probiotic supplements ([@B39]; [@B56]; [@B27]). Antibiotics or prebiotics are used to dysregulate the dysbiosis of gut microbiome in kidney disease, thereby alleviating kidney disease ([@B11]). Probiotics or antibiotics intervene in the intestinal flora of CKD to reduce harmful products produced by the gut microbiome, such as IS and PCS, which induces systemic inflammation and cardiovascular events in CKD ([@B34]). The application of probiotics or antibiotics can regulate the mucosa and reduce Harmful IgA1 production, thereby delaying the progress of IgAN ([@B10]). The application of probiotics or antibiotics can also reduce proteinuria and gut microbiome-derived phenyl sulfate ([@B31]).

Rhubarb is a well-known Chinese herbal medicine used to treat various diseases for hundreds of years in China. Researches have shown that rhubarb can treat many diseases by improving intestinal barrier function. For example, rhubarb can improve the intestinal barrier and reduce translocation of bacteria in sepsis ([@B65]). Rhubarb could protect against intestinal injury and improve intestinal mucosal barrier function in acute pancreatitis ([@B69]), as well as in hepatic inflammation ([@B46]). Studies have shown that rhubarb can regulate the gut microbiota and reduce the inflammatory response to treat type 2 diabetes, with observed increases in the probiotic *Lactobacillus* and short-chain fatty acid-producing bacteria, and decreases in the *Lachnospiraceae* NK4A136 group and LPS-producing Desulfovibrio ([@B17]).

Rhubarb is commonly used to treat kidney diseases in traditional Chinese medicine ([@B26]). Studies indicated that rhubarb or its extracts could alleviate renal fibrosis ([@B18]) and rebalance metabolic dysfunction in diabetic nephropathy ([@B76]). Recent studies have shown that there are many other natural products that can alleviate CKD progression by regulating RAS, Smad2/3-TGFβRI, TGF-β/Smad signaling pathway, and the Wnt/β-catenin pathway ([@B12]; [@B13]).

Our previous study indicated that rhubarb and emodin *via* colonic irrigation, improved systemic inflammation and kidney damage, altered levels of urea and indoxyl sulfate (IS), and changed gut microbiota in rats with CKD ([@B74]), and we have explored the dose-effect relationship of rhubarb enema, the optimal dose were selected in this study. Our present study also showed intestinal barrier injury, such as infiltration of lymphocytes and monocytes in the intestinal mucosal layer, activation of the inflammatory signaling pathway in colon tissues, decrease of intestinal tight junction proteins, and significant changes in gut microbiota of 5/6 Nx model rats. Certain probiotic gut microbiota, such as *Lactobacillus*, *Prevotellaceae* and *Parabacteroides* were decreased, whereas conditional pathogenic bacteria, such as *Methanosphaera*, *Akkermansia*, *Christensenella*, *Adlercreutzia*, *Corynebacterium*, *Coprobacillus*, *RF39* from class *Mollicutes*, *02d06* from family *Clostridiaceae*, one member of family *Erysipelotrichaceae* and two members of order *Clostridiales* were increased. Rhubarb treatment significantly inhibited overgrowth of pathogenic gut bacteria, including *Alcaligenaceae*, *Methanosphaera*, and *Clostridiaceae*.

According to researches, the anthraquinones contained in rhubarb have potential nephrotoxicity, hepatotoxicity and intestinal toxicity, such as liver fibrosis ([@B62]; [@B64]), apoptosis of human renal tubular epithelial cells ([@B73]; [@B8]), and colorectal melanosis or pseudo-melanoderma of colon ([@B79]). All the side effects mentioned above occurred in the case that rhubarb were administered orally for a long medication or overdose. In this study, safe dose of rhubarb was administered in reasonable period *via* anal enema. Anthraquinones are insoluble in water, so anthraquinones administered by enema are hardly absorbed by the intestine, thus the side effects of anthraquinones on the liver, kidneys and other organs are avoided. Until now, there are no reports of toxic effects, such as hepatotoxicity, nephrotoxicity and intestinal toxicity caused by anthraquinones enema both in clinical and animal experiments. On the contrary, in our previous and present studies, rhubarb had a protective effect on the kidney and colon, and can reduced systemic inflammation as well. No toxic reactions were observed in organs such as heart, spleen and liver. In the future, we will pay more attention to the toxicity caused by anthraquinone enema, if necessary.

In our work, UPLC was used to separate methanol pretreated samples, and a total ion chromatogram spectrum was obtained, and the peak was compared with molecular formula data and relevant literatures ([@B71]; [@B41]; [@B54]; [@B78]; [@B77]; [@B61].) to identify the structure and composition of rhubarb granules, and 5 kinds of the most studied compounds in rhubarb were identified ([**Supplementary Table 1**](#SM1){ref-type="supplementary-material"}). Our research results are practically consistent with previous research results.

The 5/6 Nx model is one of the classic models to study CKD. Other studies utilizing the 5/6 Nx model have shown that serum creatinine, urea, and proteinuria increased significantly, accompanied by intestinal barrier disruption, dysregulated mucosal Immunity, and decreased expression of HSP70 and claudin-1 in the colon, with increased pore-forming claudin-2 expression and apoptosis, promoting systemic inflammation and renal fibrosis ([@B72]; [@B29]).

The bacteria enriched in 5/6 Nx model rats mainly include *Proteobacteria*, *Betaproteobacteria*, *Enterobacteriaceae*, *Sutterellaceae*, *Clostridiaceae*, which were similar to our findings. These bacteria are related to the metabolism of lipids, amino acids, bile acids, and polyamines. These metabolites are related to CKD risk factors, such as hypertension, inflammation, and fibrosis, caused by LPS leakage. Probiotics and butyric acid can assist in improving the environment by reducing systemic inflammation and renal fibrosis ([@B29]).

Dysbiosis of the gut microbiome in UUO model rats shows that *Turicibacter*, *Acetatifactor*, *Blautia*, *Intestinimonas*, and *Oscillibacter* were enriched, with a significant difference in the metabolism of lipids, amino acids, and bile acids metabolism in plasma, which is consistent with the metabolism of intestinal flora related to renal fibrosis, intestinal barrier integrity and systemic inflammation ([@B14]). Oxalate-induced CKD also showed dysbiosis and intestinal barrier dysfunction. Although the restoration of the oxalate-free diet improved renal function to a certain extent, systemic inflammation and renal fibrosis could not be restored ([@B32]). In mice with kidney disease under sterile conditions, intestinal levels of indole-3-acetic acid, short-chain fatty acids and n-3 polyunsaturated fatty acids, which play an important role in endothelial barrier function, are significantly reduced. These metabolites originate from the flora. Metabolites may provide renal protection against renal fibrosis by inhibiting destruction of the epithelial barrier ([@B29]).

By comparing the present study with others, our results agree with other studies, indicating that rhubarb can reduce pathogenic bacteria in CKD rats, such as Lachnospiraceae and Clostridiaceae, and correct the probiotic deficiency.

In addition, functional correlation results indicated that functional KOs of gut microbiota emerged in three groups were consistent with the above results, and the correlation with inflammation was decreased, while the correlation with barrier protection was enhanced with rhubarb interventions. Researchers found that fatty acid synthase, KOs which emerged in the sham group in our research, helps maintain the mucus barrier by regulating mucin 2, the dominant mucin in the colon and a central component of mucus ([@B66]), while butanoate can protect epithelial barrier function by preventing the increase of paracellular permeability ([@B40]). L-arginine metabolites, KOs which emerged in the 5/6 Nx model group in our research, may participate in the pathogenesis of kidney disease ([@B47]). And tyrosine is digested by intestinal flora to produce phenol and p-cresol ([@B9]), which can cause system inflammation and CKD progression.

Although the functional genes of related gut microbiota and its KOs responsible for intestinal barrier damage or kidney fibrosis have not been identified very well in the present study, we made some other interesting discoveries. *Clostridium* and t*ryptophan synthesis* were positively correlated with inflammation and negatively correlated with the intestinal barrier. Moreover, *Clostridium* was correlated with urea nitrogen and IS in our previous studies ([@B74]). Therefore, we speculated that *Clostridium* contained genes related to enzymes that decompose urea to synthesize ammonia, and genes related to the synthesis of IS by decomposition of tryptophan.

In addition, we did not use a positive drug in this study, because our previous studies have shown that rhubarb enema can significantly improve renal fibrosis and system inflammation in CKD rats, accompanied by a decreased creatinine levels in blood, which may related to the intestinal flora modification by rhubarb ([@B36]; [@B74]). This is not an accidental result, since we conducted a dose-effect relationship exploration between rhubarb enema against renal fibrosis in CKD rats. The optimal dose was applied to this study. We have also tried using sevelamer hydrochloride as a positive control drug to improve renal fibrosis in CKD rats. As an adsorbent, sevelamer can decrease the toxins' lever in the intestine without being absorbed, thereby reducing system inflammation and improving kidney fibrosis ([@B53]; [@B25]), which is similar to the role of rhubarb. The preliminary results showed that the effect of rhubarb enema was better than that of sevelamer hydrochloride group. According to recent reports, CKD is usually accompanied by intestinal flora imbalance and intestinal barrier damage, they can cause enteric inflammation, which in turn causes kidney inflammation and renal fibrosis. We have clearly demonstrated that rhubarb enema can improve renal fibrosis. However, whether intestinal barrier function could be improved by rhubarb intervention and the relationship with intestinal flora are still unknown. So we focused investigated the effects of rhubarb enema on intestinal barrier, and further analysis the relationship with gut microbiota in 5/6 nephrectomy rats, and to explain the renal protective mechanism of rhubarb enema.

Taken together, our study partly confirms the hypothesis that rhubarb enema protects the kidney fibrosis by down-regulating systemic inflammation and improving the intestinal barrier in CKD, which may be related to the regulation of related gut microbiota. However, exactly which microflora is related to the barriers has not been clearly proven. In future, studies on metagenomics and flora transplantation are needed to further confirm our hypothesis.

Limitations {#s4_1}
-----------

Our results suggest that rhubarb enema significantly improved the intestinal barrier integrity in CKD, the mechanism may be related to the improvement of gut microbiota that regulates the intestinal barrier. Thus far, there are few drugs that can directly regulate the intestinal barrier. However, the correlation between flora and the intestinal barrier in the results of this study was based on bioinformatics analysis, and no relevant experimental verification has been performed.

Conclusions {#s4_2}
-----------

The mechanism of intestinal barrier integrity reduction in CKD may relate to intestinal bacteria dysbiosis, and rhubarb enema might regulate the related gut microbiota to down-regulate pathogenic bacteria, regulate intestinal TLR4 signalling pathway, improve intestinal mucosal barrier.
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